at 95℃ for 5 minutes followed by cooling to room temperature overnight, which was cloned into the expression vector pBSTNAV [2] (a gift from Luc Ponchon, Addgene Plasmid #45801) between PstI and EcoRI sites. Constructed E. coli tRNA Phe expression plasmid was transformed in BL21(DE3) cells and selected under 50 μg/ml ampicillin. Cells transformed with our constructed plasmid were grown at 37 °C in TB medium with 50 μg/ml ampicillin until OD600 = ~1.3. Total cellular tRNA was extracted as previous described.
[ 3] According to previous method, to purify tRNA Phe from total tRNA, streptavidin-agarose beads (Sigma) coated with biotinylated single stranded DNA (tRNA Phe hander, Table S4 ) complementary to part of tRNA Phe were used to isolate tRNA Phe through specific RNA/DNA heteroduplex formation. [4] tRNA Phe bound on the beads was released by heating at 65°C and concentrated through ethanol precipitation. tRNA Phe was labeled by Cy3 or CAGE FAM through reaction of NHS ester with the primary aliphatic amino group of the 3-(3-amino-3-carboxypropyl)-uridine at position 47 (acp 3 U47)
according to previous method. [5] Briefly, tRNA Phe and fluorophore were mixed at 1:20 molar ratio in 50 mM HEPES pH 8.0, 0.9 M NaCl. Mixture was kept at 30°C for 8 hours followed by additional 12 hours at 4 °C . Labeled tRNA Phe was separated from unlabeled tRNA Phe by reverse-phase HPLC using a DeltaPak C4 Column (Waters, 300Å, 15 µm, 3.9 mm  300 mm). The tRNA mixture was applied to the column equilibrated with buffer A (20 mM NH4Ac pH 7.0, 10 mM MgAc2 and 400 mM NaCl) and the labeled tRNAs were eluted with a linear gradient of buffer A containing 30% (v/v) ethanol. E. coli tRNA Val (Sigma) was labeled by Cy5-NHS and purified through the same procedure.
Aminoacyl tRNA and ternary complexes preparation E. coli Phe and Val tRNA synthetase, whose plasmids were constructed using vector pET-28a, were overexpressed in E. coli BL21 (DE3) cells and purified on a Ni-NTA column (Qiagen).
Aminoacylation mixture containing 25 μM tRNA, 100 μM L-amino acid, 12.5 μM tRNA synthetase, 10 mM ATP, 3 mM dithiothreitol, 0.005 unit/μL Thermostable Inorganic Pyrophosphatase (NEB) in 100 mM Tris-HCl pH 7.8, 50 mM MgCl 2 , and 2.5 mM EDTA were kept at 37°C for 30 minutes. Aminoacyl tRNA was purified by phenol-chloroform extraction, Nap-5 column (GE) desalting, and ethanol precipitation as previous described.
[ 1d,6] Ternary complexes were formed by incubating 8 µM EF-Tu, 1 µM aminoacyl tRNA, 3 mM GTP, 1.3 mM phosphoenolpyruvate, and 5 µg/mL pyruvate kinase in TAM 15 buffer for 15 minutes at 37 °C.
Plasmid construction, protein purification and labeling of elongation factor G (EF-G)
A cysteine-free mutant of E. coli EF-G (C113D, C265A, C397S) [7] in vector pET24b was constructed according to QuikChange site-directed mutagenesis using Q5® High-Fidelity DNA Polymerase (NEB). Ser692 of the cysteine-free mutant was mutated to Cys and confirmed by DNA sequencing. All primers (Beijing Zixi bio tech) used for mutagenesis were described in Table S4 . The EF-G S692C mutant protein was overexpressed in E. coli BL21 (DE3) cells and purified on a Ni-NTA column (Qiagen) with EF-G storage buffer (50 mM Tris-HCl pH 7.5, 70 mM NH 4 Cl, 30 mM KCl, 7 mM MgCl 2 , 1 mM TCEP).
CAGE 552 maleimide and EF-G S692C were mixed at 5:1 molar ratio in EF-G storage buffer and kept at room temperature (~23°C ) for two hours. Reactions were quenched by adding 10 mM DTT. Labeled EF-G was separated from excess free fluorophores through a desalting Sephadex G-25 column (Nap-5, GE).
Preparation of PEG-passivated slides
PEG-passivated slides were prepared according to previous procedure with minor modifications. [8] In brief, slides and coverslips were sonicated at 40 º C in the order of acetone (10 minutes), 0.2 M KOH (20 minutes), and ethanol (10 minute). Cleaned slides and coverslips were treated with amino-silane reagents (1ml 3-aminopropyltriethoxysilane, 5 ml acetic acid, and 94 ml methanol) at room temperature overnight and then incubated with polyethylene glycol (PEG from Laysan Bio, Inc., containing 20% w/w mPEG-Succinimidyl Valerate, MW 2,000 and 1% Biotin-PEG-SC, MW 2,000) in 0.1 M sodium bicarbonate (pH 8.3) for 3 h. Slides and coverslips were dried by clean N 2 , put in 50 mL falcon tubes, vacuum sealed in food saver bags, and stored it at -20 º C.
Acquisition of smFRET data PEG-passivated slides were incubated with 0.05 mg/ml streptavidin for 3 minutes. Then DNA duplexes and initiation complexes (ICs) were specifically attached to microscope flow cells via biotinylated DNA or mRNA to PEG-passivated slides, decorated with biotin-PEG and streptavidin. smFRET experiments were performed at 23 º C in TAM 15 buffer (15 mM MgAc 2 , 50 mM Tris-HCl pH 7.5, 30 mM NH 4 Cl, 70 mM KCl, and 1 mM dithiothreitol) with an oxygen scavenging system, containing 3 mg/mL glucose, 100 µg/mL glucose oxidase (Sigma-Aldrich), 40 μg/mL catalase (Roche), 1 mM cyclooctatetraene (COT, Sigma-Aldrich), 1 mM 4-nitrobenzylalcohol (NBA, Sigma-Aldrich), 1.5 mM 6-hydroxy-2,5,7,8-tetramethyl-chromane-2-carboxylic acid (Trolox, Sigma-Aldrich -added from a concentrated DMSO stock solution).
Single molecule fluorescence and FRET measurements were performed on a home-built objective-type TIRF microscope, based on a Nikon Eclipse Ti-E with an EMCCD camera (Andor iXon Ultra 897), and solid state 405 nm, 488 nm, 532 nm, and 640 nm excitation lasers (Coherent Inc. OBIS Smart Lasers) which can be modulated using digital signals from the EMCCD camera. For single molecule photoactivation FRET (sm-PAFRET), alternating laser excitation (ALEX) between 405 nm and 532 nm (or 488 nm) excitation was achieved by synchronizing laser on-off switch with EMCCD frames. Fluorescence emission from the probes was collected by the microscope and spectrally separated by interference dichroic (T550lpxr for Alexa 488/Cy5 FRET pair or T635lpxr for Cy3/Cy5 FRET pair, Chroma) and bandpass filters, ET525/50m (for Alexa 488 and CAGE FAM, Chroma) or ET585/65m (for Cy3 and CAGE 552, Chroma), and ET700/75m (for Cy5, Chroma), in a Dual-View spectral splitter (Photometrics, Inc., Tucson, AZ). All single molecule movies were collected using Cell Vision software (Beijing Coolight Technology).
Collected movies were analyzed by a custom-made software program developed as an ImageJ plugin (http://rsb.info.nih.gov/ij). Fluorescence spots were fitted by a 2-D Gaussian function within a 9-pixel by 9-pixel area, matching the donor and acceptor spots using a variant of the Hough transform. [9] The background subtracted total volume of the 2-D Gaussian peak was used as raw fluorescence intensity I. Three or more replicates were performed for each experiments. Standard error of mean (SEM) was displayed as error bar and variation.
FRET efficiency correction
Actual FRET efficiency was calculated via equation, (Eq. S1)
where I D is raw fluorescence intensity of donor, I A is raw fluorescence intensity of acceptor, and χ is the cross-talk of the donor emission into the acceptor channel. γ accounts for the differences in quantum yield and detection efficiency between the donor and the acceptor and is calculated as the ratio of change in the acceptor intensity (ΔI A ) to change in the donor intensity (ΔI D ) upon acceptor photobleaching (γ =ΔI A /ΔI D ).
[10]
Estimation of reaction rates shown in Figure 3E
Percentages of the ribosomes going through one of three parallel translocation pathways shown in Figure 3E under certain EF-G concentration can be expressed as:
in which, P 1 , P 2 , and P 3 are percentages of the ribosomes going through pathway 1 (red), pathway 2 (green), and pathway 3 (blue), respectively; [EF-G] is the concentration of EF-G; k 12 and k 23 are transition rates from PRE(I) to PRE (II) and from PRE(II) to PRE(III), respectively; k b1 and k b2 are binding rates of EF-G onto PRE(I) and PRE (II), respectively. Previous studies have shown that EF-G can interact with different ribosomal PRE states to promote translocation. [1d, 11] We assume both k b1 and k b2 are the same (150 μM -1 s -1 ). [12] P 1 , P 2 , and P 3 under five different [EF-G] were extracted from FRET distributions shown in Figure 3D and applied to Eqs. S2-S4 to perform a global fitting, which estimated values of k 12 and k 23 to be 19±3 s -1 and 6±1 s -1 , respectively.
Appearant dwell times (t app ) of EF-G bound states were weighted sum of dwell times from all parallel pathways: (Eq. S5) in which, k dG1 , k dG2 and k dG3 are dissociation rates of EF-G from EF-G bound intermediate states in pathway 1 (red), pathway 2 (green), and pathway 3 (blue), respectively. t app , P 1 , P 2 , and P 3 under five different EF-G concentrations were extracted from dwell time and FRET distributions shown in Figures 3B and 3D Figure S1 . Distributions of Cy3 SNR were shown in Figure S3 . b FRET between Cy3 and Cy5 was measured from surface attached DNA duplex formed from Cy3 labeled D-strand-I, Cy5 labeled A-strand-I and biotinylated hander-I. Distributions of Cy3/Cy5 FRET were shown in Figure S4 . Figure S2 . Distributions of Alexa 488 SNR were shown in Figure S5 . b FRET between Alexa 488 and Cy5 was measured from surface attached DNA duplex formed from Alexa 488 labeled D-strand-II, Cy5 labeled A-strand-II and biotinylated hander-II. Distributions of Alexa 488/Cy5 FRET were shown in Figure S6 . CAGE 552 and CAGE FAM were covalently attached on D-strand-I, which were immobilized on microscope slide by forming DNA duplex with unlabeled A-strand-I and biotinylated hander-I.
